Addition of Herceptin (humanized anti-HER2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2+/MBC) markedly increases anti-cancer activity: a randomised multinational controlled phase III trial
1998
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
380
Citations
NaN
KQI